-
San Diego Cell Therapy CDMO Acquired by Healthcare-Focused Private Equity Firm
contractpharma
January 12, 2022
Company also announces new name and leadership slate.
-
Kalexsyn Merges into Dipharma
contractpharma
January 05, 2022
Dipharma strengthens position in the U.S. CDMO market.
-
Piramal adds antibody CDMO capabilities with investment in Yapan Bio
CPhIonline
December 23, 2021
Transaction adds new technologies and capabilities in large molecules, including vaccines and gene therapy, to its global offering.
-
Piramal Pharma Ltd. Invests Minority Stake in CDMO Yapan Bio
contractpharma
December 22, 2021
The investment of INR 101.77 cror in biologics reflects the company’s global commitment to this fast-growing segment of the pharma industry.
-
Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan
prnasia
December 09, 2021
Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin Healthcare Limited Partnership at the 2021 Biotech Investor Forum...
-
Vetter Wins Frost & Sullivan’s 2021 Global Customer Value Leadership Award, and Looks Back on a Stable Year Under Ongoing Pandemic Circumstances
B3Cnewswire
December 08, 2021
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has been awarded the Frost & Sullivan's 2021 Global Customer Value Leadership Award in the aseptic fill & finish market...
-
Adare Pharma acquires oral formulations specialist Frontida BioPharm
CPhIonline
December 06, 2021
The combined company intends to lead in the space of oral formulations, solving customers' complex formulation challenges.
-
ST Pharm to construct second oligonucleotide facility in Korea
CPhIonline
December 03, 2021
The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025.
-
ANI Pharma enhances generics and CDMO business through Novitium acquisition
CPhIonline
November 29, 2021
The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business.
-
Micro-Sphere Expands Capabilities with $3.5M Investment
ContractPharma
November 09, 2021
Micro-Sphere has added to its contract development and manufacturing expertise with new spray drying technology and increased high containment capabilities.